Skip to main content
OSTEOPORE LIMITED logo

OSTEOPORE LIMITED — Investor Relations & Filings

Ticker · OSX ISIN · AU0000053324 ASX Manufacturing
Open in API
Filings indexed 488 across all filing types
Latest filing 2023-10-30 Interim / Quarterly Rep…
Country AU Australia
Listing ASX OSX

About OSTEOPORE LIMITED

https://osteopore.com

Osteopore Limited specializes in the design and manufacture of 3D-printed bioresorbable implants. The company utilizes a patented 3D printing process to create scaffolds from bioresorbable polymers, such as polycaprolactone, designed to mimic the natural microstructure of bone. These implants, including the Osteoplug, Osteomesh, and Osteostrip product lines, are applied in neurosurgical, craniofacial, and orthopedic procedures to facilitate bone healing and tissue regeneration. The scaffolds provide a temporary structural framework that supports the body's natural healing process before being gradually absorbed and replaced by the patient's own bone tissue. This technology aims to reduce long-term complications associated with permanent foreign implants by promoting natural tissue integration and restoration across various clinical applications.

Recent filings

Filing Released Lang Actions
Activities Update Qtr Ending September 2023 and Appendix 4C 20 pages 3.8MB
Interim / Quarterly Report Classification · 100% confidence The document is a quarterly results announcement for Osteopore Limited, including detailed financial data such as revenues, cash flow statements, and Appendix 4C cash flow report for the quarter ending 30 September 2023. It contains substantive financial data and analysis for a period shorter than a full fiscal year (quarterly). The presence of the Appendix 4C, which is a standard Australian Securities Exchange (ASX) quarterly cash flow report, confirms this is an Interim / Quarterly Report. The document is about quarterly financial performance and cash flows, not a full annual report or just an announcement of a report. Therefore, the correct classification is Interim / Quarterly Report (IR). Q3 2023
2023-10-30 English
Change of Director's Interest Notice 12 pages 569.1KB
Director's Dealing Classification · 100% confidence The document is titled 'Appendix 3Y – Change of Director’s Interest Notice' and contains detailed disclosures about changes in securities holdings by company directors, including performance rights issued to directors. It references ASX Listing Rules 3.19A and 3.19B, which pertain to director's interest disclosures. The document is a formal notification to the ASX about directors' personal share transactions and interests. There is no indication of financial results, management discussion, or other report types. The content matches the definition of Director's Dealing filings, which report personal share transactions by company directors and executives (insider trades). The document length is substantial and contains detailed transaction data, confirming it is the actual notice rather than a brief announcement or certification.
2023-10-04 English
Investor Webinar Presentation 2 pages 358.7KB
Investor Presentation Classification · 95% confidence The document is an ASX announcement dated 18 September 2023, inviting shareholders to an investor webinar presentation scheduled for 19 September 2023. It includes details about the company's strategy update, global expansion, and a Q&A session with the Executive Chairman. The document is relatively short (2911 characters) and serves as an invitation and announcement for an upcoming investor presentation event rather than the presentation itself or a detailed report. There are no financial statements or substantive financial data included. Therefore, this document fits the category of an Investor Presentation announcement rather than a full report or earnings release.
2023-09-17 English
Clarification Announcement 3 pages 364.3KB
Capital/Financing Update Classification · 95% confidence The document is an ASX announcement dated 18 September 2023 from Osteopore Limited. It clarifies details about a previously announced Memorandum of Understanding (MOU) with InnoVentures regarding a joint venture for commercializing products in China. The content focuses on clarifying the status of the MOU, the expected timeline for regulatory approval, and the withdrawal of a previous disclosure about a prospective investor relationship. There are no financial statements, detailed financial data, or comprehensive report content. The document is a corporate announcement about a business development and joint venture progress, not a full report or financial filing. It is not an earnings release, annual or interim report, or any regulatory certification. It is an update on a capital/financing-related activity (joint venture formation and MOU clarification). Therefore, the most appropriate classification is Capital/Financing Update (CAP). The document length is 4628 characters, which is sufficient for a substantive announcement rather than a brief notice or report publication announcement.
2023-09-17 English
MOU with Temasek-linked Innoventures - Orthopaedics in China 5 pages 407.5KB
Capital/Financing Update Classification · 95% confidence The document is an ASX announcement dated 12 September 2023 regarding Osteopore signing a Memorandum of Understanding (MOU) with InnoVentures to progress expansion in China through a joint venture. The content focuses on the business agreement, strategic partnership, and future plans for commercialization. There are no financial statements, quarterly or annual results, nor detailed financial data or management discussion of financial performance. The document is a corporate announcement about a capital and strategic partnership development, specifically a joint venture and licensing agreement. This fits the category of Capital/Financing Update (CAP), as it relates to company fundraising, financing activities, or capital structure changes through the JV equity arrangement and licensing terms. The document length (9117 characters) and detailed content confirm it is not a brief notice or a report publication announcement. Therefore, the classification is CAP with high confidence.
2023-09-11 English
Resignation of Joint Company Secretary 1 page 345.9
Board/Management Information Classification · 100% confidence The document is an ASX announcement dated 4 September 2023 regarding the resignation of a joint Company Secretary. It details a change in the company's senior management position and confirms the appointment of the primary person responsible for communications with ASX. There is no financial data, report, or presentation included. The content fits the category of announcements about changes in the company's board or senior management.
2023-09-03 English

Browse filings by year

8 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.